Спирива Респимат

Спирива Респимат (tiotropium bromide) is an inhaled bronchodilator used to maintain airflow in chronic obstructive pulmonary conditions. This long-acting anticholinergic helps keep airways open for 24 hours with once-daily dosing. Ideal for COPD and asthma maintenance therapy. Prescription required in most regions.

Tiotropium bromide is primarily used to relieve symptoms and improve breathing in adults with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. It is also prescribed as a maintenance treatment for asthma in patients who require long-term control of symptoms. The medication works by relaxing muscles around the airways to keep them open, making it easier to breathe over time.

Users typically notice improved breathing comfort within the first few days of regular use. The medication helps reduce wheezing, shortness of breath, and chest tightness by maintaining open airways throughout the day and night. Some people report feeling less dependent on rescue inhalers once the maintenance routine is established.

Keep the device dry and avoid exposing it to extreme temperatures. Store the Respimat inhaler at room temperature and discard after the labeled number of doses. Rinse your mouth after use to minimize dryness or irritation. Do not share your inhaler with others to prevent cross-contamination.

Alcohol may enhance drowsiness or dizziness in some users. Other inhaled anticholinergics should not be used simultaneously to avoid additive effects. Caution is advised when combining with medications that slow heart rate or lower blood pressure. Always inform your healthcare provider about all prescription and over-the-counter products you are using.